文献速递外周动脉疾病

间歇性跛行外周血管干预后截肢的相关因素

Factors Associated with Amputation after Peripheral Vascular Intervention for Intermittent Claudication.
PubMed 文献 · Ann Vasc Surg · 2019-09-05

本研究基于美国血管质量倡议数据库2003至2017年数据,回顾性分析11,887例因间歇性跛行行择期外周血管干预的患者。结果显示大截肢和小截肢合计发生率为1.08%,术前症状性充血性心力衰竭、ASA IV级、非白人种族及仅行胫动脉干预与截肢风险升高相关。

要点

  • 间歇性跛行患者外周血管干预后1年小截肢率0.56%、大截肢率0.51%。
  • 术前症状性心衰、ASA IV级及非白人种族显著增加大截肢风险。
  • 仅行胫动脉干预与任何截肢风险升高相关。

核心结论

  • 间歇性跛行的自然史在截肢方面似乎未受外周血管干预影响。
  • 病情更重的患者(ASA分级更高或症状性充血性心力衰竭)及仅行胫动脉干预者截肢风险更高,但无法确定是否归因于患者基础状态、表现或干预本身。
  • 关键的术前和术中指标有助于临床医生预测截肢风险较高的患者。

研究设计与样本

  • 回顾性队列研究,数据来源于美国PVI血管质量倡议数据库,纳入2003至2017年因间歇性跛行行择期治疗且无既往下肢PVI或旁路手术史的患者。

主要发现

  • 共识别11,887例外周血管干预手术。
  • 大截肢和小截肢合计发生率为1.08%(n=128)。
  • 1年时小截肢发生率为0.56%(n=67),大截肢为0.51%(n=61)。
  • 术前踝肱指数(ABI)<0.2或不可压缩ABI(>1.3)的患者任何截肢率显著高于ABI在0.20-0.49、0.50-0.89和0.90-1.30之间的患者(log rank,<0.001)。
  • 多因素分析显示,术前症状性充血性心力衰竭(OR,6.48;95%CI,2.43-17.20;P<0.001)、ASA IV级(OR,9.34;95%CI,1.94-44.89;P=0.005)和非白人种族(OR,3.32;95%CI,1.50-7.36;P=0.003)显著增加PVI后大截肢风险。

临床怎么用

  • 对于间歇性跛行患者,术前应评估症状性充血性心力衰竭、ASA分级及种族因素以识别截肢高风险者。
  • 术前ABI<0.2或>1.3(不可压缩)提示截肢风险显著升高,需加强监测。
  • 仅行胫动脉干预时需警惕大截肢和小截肢风险增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The natural history of intermittent claudication (IC) is that only 25% of patients will experience worsening of their claudication symptoms, and only approximately 1-3% will progress to major amputation. The impact of increasing use of endovascular therapies on the natural history of IC has not been well established. The purpose of this study is to evaluate the incidence and identify predictors of major and minor amputations after peripheral vascular intervention (PVI) for IC. METHODS: A retrospective cohort of patients treated for IC was derived from the national PVI Vascular Quality Initiative database evaluating both preoperative and intraoperative variables from 2003 to 2017. We examined rates of major or minor amputations after ipsilateral PVI for IC. Multivariable logistic regression models were created to identify predictors of amputation along with Kaplan-Meier (KM) plots to estimate amputation-free survival. RESULTS: We identified 11,887 PVI procedures for patients undergoing elective treatment for IC without a previous history of lower extremity PVI or bypass. Major and minor amputations occurred at a combined rate of 1.08% (n = 128). Minor amputations occurred in 0.56% (n = 67) of patients at 1 year, whereas major amputations were reported in 0.51% (n = 61) of cases. KM plots of amputation-free survival revealed that patients with preoperative ankle brachial indexes (ABIs) <0.2 or noncompressible ABIs (>1.3) had significantly higher rates of any amputation compared with subjects with ABIs between 0.20-0.49, 0.50-0.89, and 0.90-1.30 (log rank, <0.001). Multivariate analysis showed that patients with preoperative symptomatic congestive heart failure (CHF) (odds ratio [OR], 6.48; 95% confidence interval [95% CI], 2.43-17.20; P < 0.001), American Society of Anesthesiologists (ASA) class IV (OR, 9.34; 95% CI, 1.94-44.89; P = 0.005), and nonwhite race (OR, 3.32; 95% CI, 1.50-7.36; P = 0.003) had significant increase in risk of major amputation after PVI. Odds of major or minor amputation were increased when patients underwent only a tibial-level intervention (major: OR, 6.26; 95% CI, 1.50-26.10; P = 0.012 and minor: OR, 7.04; 95% CI, 1.02-8.51; P = 0.001). CONCLUSIONS: With relation to amputation, the natural history of IC does not appear to be impacted by PVI sicker patients with higher ASA or symptomatic CHF, and those with isolated tibial interventions are at higher risk for amputation, and we cannot determine if this is due to patient substrate, presentation, or the intervention itself. Importantly, there are key prognostic preoperative and intraoperative indicators that can assist the clinician with predicting patients who are at a higher risk of amputation.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Axley JC, McFarland GE, Novak Z, et al. Factors Associated with Amputation after Peripheral Vascular Intervention for Intermittent Claudication. Ann Vasc Surg. 2019. PMID: 31494265. doi:10.1016/j.avsg.2019.08.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。